LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts $89.69 -1.83 (-2.00%) (As of 10/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateOct. 31After Market ClosesConfirmedActual EPS (Aug. 1) $0.52 Beat By $0.05 Consensus EPS (Aug. 1) $0.47 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Get LeMaitre Vascular Earnings AlertsEnter your email address below to receive the latest news and earnings results for LMAT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLMAT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LMAT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. LeMaitre Vascular Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.40$0.40$0.400.360 - 0.410Q2 20241$0.47$0.47$0.470.450 - 0.500Q3 20241$0.40$0.40$0.400.420 - 0.460Q4 20242$0.41$0.43$0.42 FY 20245$1.68$1.70$1.69 Q1 20252$0.44$0.50$0.47 Q2 20252$0.51$0.53$0.52 Q3 20252$0.44$0.49$0.47 Q4 20252$0.47$0.52$0.50 FY 20258$1.86$2.04 $1.95LMAT Earnings Date and InformationLeMaitre Vascular last announced its earnings results on August 1st, 2024. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.05. The business had revenue of $55.85 million for the quarter, compared to the consensus estimate of $54.98 million. Its revenue for the quarter was up 11.4% on a year-over-year basis. LeMaitre Vascular has generated $1.51 earnings per share over the last year ($1.51 diluted earnings per share) and currently has a price-to-earnings ratio of 53.7. Earnings for LeMaitre Vascular are expected to grow by 12.97% in the coming year, from $1.85 to $2.09 per share. LeMaitre Vascular has confirmed that its next quarterly earnings report will be published on Thursday, October 31st, 2024. LeMaitre Vascular will be holding an earnings conference call on Thursday, October 31st at 5:00 PM Eastern. Interested parties can register for or listen to the call.. Read More LeMaitre Vascular Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/31/2024(Confirmed)------- 8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98 million$55.85 million 5/2/2024Q1 2024$0.39$0.44+$0.05$0.44$51.50 million$53.48 million 2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01 million$48.90 million 11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58 million$47.40 million 8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29 million$50.12 million 5/2/2023Q1 2023$0.25$0.27+$0.02$0.27$43.54 million$47.08 million Get the Latest News and Ratings for LMAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter. 2/23/2023Q4 2022$0.26$0.25($0.01)$0.25$40.99 million$41.00 million 10/27/2022Q3 2022$0.28$0.25($0.03)$0.25$40.13 million$39.03 million 7/28/2022Q2 2022$0.32$0.29($0.03)$0.42$41.26 million$42.11 million 4/28/2022Q1 2022$0.28$0.27($0.01)$0.27$38.65 million$39.56 million 2/24/2022Q4 2021$0.31$0.28($0.03)$0.28$39.70 million$39.50 million 10/28/2021Q3 2021$0.33$0.30($0.03)$0.30$39.05 million$38.37 million 7/29/2021Q2 2021$0.34$0.40+$0.06$0.40$40.70 million$40.67 million 4/29/2021Q1 2021$0.28$0.28-$0.28$35.55 million$35.88 million 2/25/2021Q4 2020$0.31$0.34+$0.03$0.34$35.87 million$37.55 million 10/29/2020Q3 2020$0.19$0.37+$0.18$0.37$31.62 million$36.42 million 7/23/2020Q2 2020$0.01$0.17+$0.16$0.17$15.58 million$24.85 million 4/30/2020Q1 2020$0.16$0.16-$0.16$30.50 million$30.55 million 2/6/2020Q4 2019$0.23$0.23-$0.23$30.44 million$30.20 million 10/23/2019Q3$0.21$0.25+$0.04$0.25$28.15 million$29.10 million LeMaitre Vascular Earnings - Frequently Asked Questions When is LeMaitre Vascular's earnings date? LeMaitre Vascular has confirmed that its next quarterly earnings data will be published on Thursday, October 31st, 2024. Learn more on LMAT's earnings history. What guidance has LeMaitre Vascular issued on next quarter's earnings? LeMaitre Vascular issued an update on its third quarter 2024 earnings guidance on Thursday, August, 1st. The company provided earnings per share (EPS) guidance of 0.420-0.460 for the period, compared to the consensus estimate of 0.420. The company issued revenue guidance of $52.7 million-$54.7 million, compared to the consensus revenue estimate of $52.4 million. Did LeMaitre Vascular beat their earnings estimates last quarter? In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.05. Learn more on analysts' earnings estimate vs. LMAT's actual earnings. How can I listen to LeMaitre Vascular's earnings conference call? The conference call for LeMaitre Vascular's latest earnings report can be listened to online. Listen to Conference Call How can I read LeMaitre Vascular's conference call transcript? The conference call transcript for LeMaitre Vascular's latest earnings report can be read online. Read Transcript How much revenue does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $205.62 million. How much profit does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.51 earnings per share over the last four quarters. What is LeMaitre Vascular's price-to-earnings ratio? LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 53.71 and a forward price-to-earnings ratio of 48.48. The price/earnings-to-growth ratio is 2.45. What is LeMaitre Vascular's EPS forecast for next year? LeMaitre Vascular's earnings are expected to grow from $1.85 per share to $2.09 per share in the next year, which is a 12.97% increase. More Earnings Resources from MarketBeat Related Companies: VAPO Earnings PEN Earnings GKOS Earnings INSP Earnings MMSI Earnings STVN Earnings ICUI Earnings HAE Earnings PRCT Earnings AXNX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles: Taiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth? This page (NASDAQ:LMAT) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
